Nonadherence to clinic appointments among HIV-infected children in an ambulatory care program in western Kenya

Journal of Acquired Immune Deficiency Syndromes

Volumn 63, Issue 2, 2013, Pages

  Nyandiko, Winstone ^a,b,c   Vreeman, Rachel ^b,d   Liu, Hai ^b,d   Shangani, Sylvia ^b,c   Sang, Edwin ^b   Ayaya, Samuel ^a,b,c   Braitstein, Paula ^a,b,d,e  

^a MOI UNIVERSITY   (Kenya)

^b ACADEMIC MODEL PROVIDING ACCESS TO HEALTHCARE AMPATH   (Kenya)

^c MOI TEACHING AND REFERRAL HOSPITAL   (Kenya)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

CDC stage; Children; Clinic adherence; HIV infected; Immune suppression; Lost tofollow up; WAZ and WHZ scores

Indexed keywords

AMBULATORY CARE; ARTICLE; CHILD; CHILD CARE; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HOSPITAL MANAGEMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; KENYA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT REFUSAL; ACQUIRED IMMUNE DEFICIENCY SYNDROME; MEDICATION COMPLIANCE; MORTALITY; OUTPATIENT DEPARTMENT; PATIENT COMPLIANCE; TREATMENT OUTCOME;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AMBULATORY CARE; AMBULATORY CARE FACILITIES; ANTI-HIV AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; KENYA; MALE; MEDICATION ADHERENCE; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84879768977     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31828e1e2c     Document Type: Article

References (37)

1. Doerholt K, Duong T, Tookey P, et al. Outcomes for human immunodeficiency virus-1-infected infants in the United kingdom and Republic of Ireland in the era of effective antiretroviral therapy. Pediatr Infect Dis J. 2006;25:420-426.
2. Gibb DM, Goodall RL, Giacomet V, et al. Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. Pediatr Infect Dis J. 2003;22:56-62.
3. Hogg RS, Heath KV, Yip B, et al. Improved survival among HIV-in-fected individuals following initiation of antiretroviral therapy. JAMA. 1998;279:450-454.
4. Needham DM, Hogg RS, Yip B, et al. The impact of antiretroviral therapy on AIDS survival observed in a province-wide drug treatment programme. Int J STD AIDS. 1998;9:370-372.
5. World Health Organization. Progress on Global Access to HIV Antire-troviral Therapy: A Report on "3 by 5" and Beyond. Geneva, Switzerland: World Health Organization; 2006.
6. Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med. 1999;131:81-87.
7. Rastegar DA, Fingerhood MI, Jasinski DR. Highly active antiretroviral therapy outcomes in a primary care clinic. AIDS Care. 2003;15:231-237.
8. Mullen J, Leech S, O'Shea S, et al. Antiretroviral drug resistance among HIV-1 infected children failing treatment. J Med Virol. 2002; 68:299-304.
9. San-Andres FJ, Rubio R, Castilla J, et al. Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997. Clin Infect Dis. 2003;36:1177-1185.
10. UNAIDS, UNHRC, UNICEF, et al. 2006 Report on the Global AIDS Epidemic. Geneva, Switzerland: UNAIDS; 2006.
11. Giordano TP, Gifford AL, White AC Jr, et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis. 2007;44: 1493-1499.
12. Zhang Y, Dou Z, Sun K, et al. Association between missed early visits and survival among patients of China national free ART cohort. J Acquir Immune Defic Syndr. 2012;60:59-67.
13. Brennan A, Maskew M, Sanne I, et al. Importance of clinic attendance in the first 6 months on ART: missing medical visits increases mortality. J Int AIDS Soc. 2010;13:49.
14. Lee VJ, Earnest A, Chen MI, et al. Predictors of failed attendances in a multi-specialty outpatient centre using electronic databases. BMC Health Serv Res. 2005;5:51.
15. Vreeman RC, Wiehe SE, Ayaya SO, et al. Association of antiretroviral and clinic adherence with orphan status among HIV-infected children in Western Kenya. J Acquir Immune Defic Syndr. 2008;49:163-170.
16. UNICEF. The State of the World's Children 2007. New York, NY: UNICEF; 2007.
17. Watts H, Gregson S, Saito S, et al. Poorer health and nutritional outcomes in orphans and vulnerable young children not explained by greater exposure to extreme poverty in Zimbabwe. Trop Med Int Health. 2007; 12:584-593.
18. Lindblade KA, Odhiambo F, Rosen DH, et al. Health and nutritional status of orphans, 6 years old cared for by relatives in western Kenya. Trop Med Int Health. 2003;8:67-72.
19. Ayaya SO, Esamai FO, Rotich J, et al. Socio-economic factors predisposing under five-year-old children to severe protein energy malnutrition at the Moi Teaching and Referral Hospital, Eldoret, Kenya. East Afr Med J. 2004;81:415-421.
20. Sarker M, Neckermann C, Muller O, Assessing the health status of young AIDS and other orphans in Kampala, Uganda. Trop Med Int Health. 2005;10:210-215.
21. Monasch R, Boerma JT. Orphanhood and childcare patterns in sub-Saharan Africa: an analysis of national surveys from 40 countries. AIDS. 2004;18 (suppl 2):S55-S65.
22. Bicego G, Rutstein S, Johnson K. Dimensions of the emerging orphan crisis in sub-Saharan Africa. Soc Sci Med. 2003;56:1235-1247.
23. Crampin AC, Floyd S, Glynn JR, et al. The long-term impact of HIV and orphanhood on the mortality and physical well-being of children in rural Malawi. AIDS. 2003;17:389-397.
24. Ryder RW, Kamenga M, Nkusu M, et al. AIDS orphans in Kinshasa, Zaire: incidence and socioeconomic consequences. AIDS. 1994;8: 673-679.
25. Einterz RM, Kelley CR, Mamlin JJ, et al. Partnerships in international health. The Indiana University-Moi University experience. Infect Dis Clin North Am. 1995;9:453-455.
26. Voelker R. Conquering HIV and stigma in Kenya. JAMA. 2004;292:157-159.
27. Mamlin J, Kimaiyo S, Nyandiko W, et al. Academic Institutions Linking Access to Treatment and Prevention: Case Study. Geneva, Switzerland: World Health Organization; 2004.
28. Inui TS, Nyandiko WM, Kimaiyo SN, et al. AMPATH: living proof that no one has to die from HIV. J Gen Intern Med. 2007;22:1745-1750.
29. Siika AM, Rotich JK, Simiyu CJ, et al. An electronic medical record system for ambulatory care of HIV-infected patients in Kenya. Int J Med Inform. 2005;74:345-355.
30. Cohen J, Kimaiyo S, Nyandiko W, et al. Addressing the educational void during the antiretroviral therapy rollout. AIDS. 2004;18:2105-2106.
31. R Development Core Team. A Language and Environment for Statistical Computing. Vienna, Austria: The R Foundation for Statistical Computing; 2011.
32. Braitstein P, Siika A, Hogan J, et al. A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment. J Int AIDS Soc. 2012;15:7.
33. Siika AM, Ayuo PO, Sidle MJ, et al. Admission characteristics, diagnoses and outcomes of HIV-infected patients registered in an ambulatory HIV-care programme in western Kenya. East Afr Med J. 2008;85: 523-528.
34. Patel K, Hernán MA, Williams PL, et al. Long-term effectiveness of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting. Clin Infect Dis. 2008;46:1751-1760.
35. Braitstein P, Songok J, Vreeman RC, et al. "Wamepotea" (they have become lost): outcomes of HIV-positive and HIV-exposed children lost to follow-up from a large HIV treatment program in western Kenya. J Acquir Immune Defic Syndr. 2011;57:e40-e60.
36. Braitstein P, Katschke A, Shen C, et al. Retention of HIV-infected and exposed children in a comprehensive HIV clinical care program in Western Kenya. Trop Med Int Health. 2010;15:833-841.
37. Pop-Eleches C, Thirumurthy H, Habyarimana JP, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011;25:825-834.